Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001231615-25-000004

Director sold 36,694 shares at an average $120.05 ($4,405,216)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

JEFFS ROGER · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-22 Sale : show line 1 in the form 10b5-1 −16,694 $120.08 $2,004,616 150,974 D
2025-08-26 Sale : show line 2 in the form 10b5-1 −20,000 $120.03 $2,400,600 130,974 D
Open-market sales · 36,694 sh · avg $120.05 · $4,405,216
Loading xslF345X05/ownership.xml…